Allergy & Immunology Doctors in Knoxville, TN Accepting Medicare

8 Allergy & Immunology doctors found. Showing 1 - 8

Sangeetha Kodoth, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 1346 Dowell Springs Blvd, Knoxville, TN 37909 Phone: 865-588-2753    Fax: 865-588-7418

Dr. Laura Sawyer Green, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 801 N Weisgarber Rd Ste 200, Knoxville, TN 37909 Phone: 865-584-5727    Fax: 865-584-3364

Andrew Michael Singer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2121 Highland Ave, Knoxville, TN 37916 Phone: 865-525-2640    Fax: 865-525-9536

Shirley Bannister Avery, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 822 Westborough Rd, Knoxville, TN 37909 Phone: 865-693-0875

Jane Rasnick Conley, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8001 Weisgarber Road, Suite 200, Knoxville, TN 37909 Phone: 865-584-8588    Fax: 865-584-3364

Jeffrey L Schlactus, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 801 N Weisgarber Rd, Suite 200, Knoxville, TN 37909 Phone: 865-584-8588    Fax: 865-584-3364

Dr. Timothy C. Frazier, Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 2121 Highland Ave, Knoxville, TN 37916 Phone: 865-525-2640    Fax: 865-525-9536

Dr. Marek M Pienkowski, M.D., PH.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 7417 Kingston Pike, Suite 101, Knoxville, TN 37919 Phone: 865-584-4112    Fax: 865-588-5140

News Archive

Researchers discover signaling system that halts the growth of a childhood brain cancer

A discovery by St. Jude Children's Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor.

Needle-free nanopatch vaccine delivery system

The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers from California in the United States have conducted a study showing that important adaptive immune responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not affected by four recently emerged variants of the virus.

Aspire Capital Fund to purchase Bionovo shares of common stock worth $15.0 million

Bionovo, Inc. (Nasdaq: BNVI) announced today that it has entered into a common stock purchase agreement with Aspire Capital Fund LLC, an Illinois limited liability company, which provides that, subject to certain conditions and limitations, Aspire Capital is committed to purchase up to an aggregate of $15.0 million of Bionovo shares of common stock over a two year term, based on prevailing market prices over a period preceding each sale.

Read more Medical News

› Verified 2 days ago